Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer
Guannan Wang,* Xu Wang,* Meng Han, Xiaoming Wang Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaoming WangDepartment of Hepatobiliary Sur...
Main Authors: | Wang G, Wang X, Han M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/loss-of-dab2ip-contributes-to-cell-proliferation-and-cisplatin-resista-peer-reviewed-article-OTT |
Similar Items
-
Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma
by: Zheng L, et al.
Published: (2017-11-01) -
The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer
by: Desmond R. Harrell Stewart, et al.
Published: (2020-12-01) -
Rab18 overexpression promotes proliferation and chemoresistance through regulation of mitochondrial function in human gastric cancer
by: Wu B, et al.
Published: (2018-11-01) -
DAB2IP modulates primary cilia formation associated with renal tumorigenesis
by: Chun-Jung Lin, et al.
Published: (2021-01-01) -
Polygonum multiflorum and Codonopsis pilosula granule alleviates atherosclerosis by inhibiting the expression of DAB2IP-ASK1 pathway in vascular endothelial cells
by: Jiajia Zheng, et al.
Published: (2020-01-01)